Advertisement
MIRM vs PTCT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRM is a Hold and PTCT is a Hold.
MIRM's RSI Indicator ascends from oversold territory
The RSI Indicator for MIRM moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In 12 of the 13 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for MIRM just turned positive on October 12, 2026. Looking at past instances where MIRM's MACD turned positive, the stock continued to rise in 42 of 48 cases over the following month. The odds of a continued upward trend are 88%.
Following a +3.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRM advanced for three days, in 235 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
MIRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MIRM as a result. In 59 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The 50-day moving average for MIRM moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for MIRM entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. MIRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (26.596) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (8.842) is also within normal values, averaging (437.542).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
PTCT sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for PTCT moved below the 200-day moving average on September 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTCT as a result. In 67 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for PTCT turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 31 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for PTCT entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PTCT's RSI Indicator exited the oversold zone, 21 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +0.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTCT advanced for three days, in 225 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
PTCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. PTCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PTCT's P/B Ratio (1666.670) is very high in comparison to the industry average of (26.782). P/E Ratio (7.508) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (6.094) is also within normal values, averaging (437.542).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MIRM | PTCT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 13 | 61 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 39 | 71 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 64 | 74 | |
P/E GROWTH RATING 1..100 | 100 | 30 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MIRM's Valuation (69) in the null industry is in the same range as PTCT (99) in the Biotechnology industry. This means that MIRM’s stock grew similarly to PTCT’s over the last 12 months.
MIRM's Profit vs Risk Rating (39) in the null industry is in the same range as PTCT (71) in the Biotechnology industry. This means that MIRM’s stock grew similarly to PTCT’s over the last 12 months.
MIRM's SMR Rating (100) in the null industry is in the same range as PTCT (100) in the Biotechnology industry. This means that MIRM’s stock grew similarly to PTCT’s over the last 12 months.
MIRM's Price Growth Rating (64) in the null industry is in the same range as PTCT (74) in the Biotechnology industry. This means that MIRM’s stock grew similarly to PTCT’s over the last 12 months.
PTCT's P/E Growth Rating (30) in the Biotechnology industry is significantly better than the same rating for MIRM (100) in the null industry. This means that PTCT’s stock grew significantly faster than MIRM’s over the last 12 months.
| MIRM | PTCT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 75% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 79% |
| Momentum ODDS (%) | 5 days ago 61% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 88% | 1 day ago 70% |
| TrendWeek ODDS (%) | 1 day ago 68% | 1 day ago 76% |
| TrendMonth ODDS (%) | 1 day ago 67% | 1 day ago 75% |
| Advances ODDS (%) | 3 days ago 76% | 12 days ago 80% |
| Declines ODDS (%) | 12 days ago 64% | 4 days ago 78% |
| BollingerBands ODDS (%) | 1 day ago 84% | 1 day ago 83% |
| Aroon ODDS (%) | 1 day ago 59% | 1 day ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MIRM’s FA Score shows that 0 FA rating(s) are green while PTCT’s FA Score has 1 green FA rating(s).
- MIRM’s FA Score: 0 green, 5 red.
- PTCT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MIRM’s TA Score shows that 5 TA indicator(s) are bullish while PTCT’s TA Score has 4 bullish TA indicator(s).
- MIRM’s TA Score: 5 bullish, 4 bearish.
- PTCT’s TA Score: 4 bullish, 5 bearish.
Price Growth
MIRM (@Biotechnology) experienced а -6.82% price change this week, while PTCT (@Biotechnology) price change was -8.44% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
Reported Earning Dates
MIRM is expected to report earnings on Nov 17, 2026.
PTCT is expected to report earnings on Oct 22, 2026.
Industries' Descriptions
@Biotechnology (-10.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ARCM | 100.07 | N/A | N/A |
| Arrow Reserve Capital Management ETF (ARCM) | |||
| FDHY | 47.61 | -0.07 | -0.15% |
| Fidelity Enhanced High Yield ETF (FDHY) | |||
| TAOZ | 89.56 | -0.68 | -0.75% |
| Thornburg American Opportunities Fund (TAOZ) | |||
| VCR | 375.83 | -3.88 | -1.02% |
| Vanguard Consumer Discretionary ETF (VCR) | |||
| AMDW | 83.06 | -6.50 | -7.26% |
| Roundhill AMD WeeklyPay ETF | |||
MIRM and
Correlation & Price change
A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with XERS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then XERS could also see price increases.
| Ticker / NAME | Correlation To MIRM | 1D Price Change % | ||
|---|---|---|---|---|
| MIRM | 100% | -2.73% | ||
| XERS - MIRM | 45% Loosely correlated | +2.38% | ||
| KURA - MIRM | 43% Loosely correlated | -6.39% | ||
| EXEL - MIRM | 42% Loosely correlated | -0.95% | ||
| PTCT - MIRM | 41% Loosely correlated | -2.87% | ||
| ORKA - MIRM | 40% Loosely correlated | -2.63% | ||
More | ||||